These associations remained statistically significant upon correction for expression of the UGT2B17 gene, encoding an androgen-inactivating enzyme and previously associated with poor prognosis in CLL patients [18, 19]. Here, UGT2B17 is linked to B-cell chronic lymphocytic leukemia.